Topics
Metastases to the CNS | Treatment | Clinical trials | Breast Cancer
Home > Publications > Topics > Metastases to the CNS > Treatment > Clinical trials > Breast Cancer
Bartsch R, Marhold M, Garde-Noguera J, Gion M, Ruiz-Borrego M,
Greil R, Valero M, Llombart-Cussac A, García-Mosquera JJ,
Arumi M, Cortés J, Campolier M, Guerrero JA, Slebe F,
Martínez-García E, Jiménez-Cortegana C,
Vaz-Batista M, Oberndorfer F, Furtner J, Fuereder T, Berghoff AS,
Preusser M.
Patritumab deruxtecan
(HER3-DXd) in patients with active brain metastases of breast
cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trial.
Lancet
Oncol. 2025 Oct 27;26(11):1467-1478. doi:
10.1016/S1470-2045(25)00470-X. PMID:
41167215. Interventional
study˰